Skin & Cosmetic Peptides
Cosmetic peptides have different identities, delivery methods and evidence. This hub separates human topical findings, oral collagen studies and supplier or laboratory claims so readers can compare like with like.
Category Overview
Topical cosmetics, oral supplements and injected medicines have different delivery and safety requirements. A proposed collagen or neurotransmitter mechanism does not show that a finished serum reaches its target or improves a clinical outcome.
GHK-Cu (copper peptide) has mixed topical findings. In a randomized post-laser study with 13 completers, objective redness, wrinkle and skin-quality outcomes did not differ between groups; patient satisfaction favored the GHK-Cu regimen. Read the primary study abstract.
A 12-week, split-face study in 93 women found improved fine lines and wrinkles with a moisturizer containing 3 ppm pal-KTTKS (Matrixyl study abstract). A separate four-week randomized study in 60 Chinese adults reported favorable peri-orbital wrinkle findings with Argireline (Argireline study abstract). These are formulation-specific cosmetic outcomes, not direct comparisons with injected botulinum toxin.
Oral collagen is a nutritional approach with different exposures. An eight-week randomized study in 69 women reported improved skin elasticity, while moisture and evaporation comparisons were not significant. Read the primary trial abstract. Positive studies should be read alongside product differences and study-quality concerns.
Skin & Cosmetic Peptide Names
Copper-binding tripeptide with laboratory research and mixed topical human findings. A positive wound or cosmetic study applies to its actual formulation and setting.
Pal-KTTKS, a specific cosmetic pentapeptide. A 12-week controlled study in 93 women reported improved fine lines and wrinkles with its tested moisturizer.
A marketed blend of palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7. It is distinct from the original pal-KTTKS ingredient; results cannot be transferred automatically between them.
Acetyl hexapeptide-8, also historically called acetyl hexapeptide-3. A small placebo-controlled trial reported improved peri-orbital wrinkles; this does not establish equivalence to injected botulinum toxin.
A cosmetic signaling-peptide ingredient used alone or in blends. A blend study cannot establish the contribution of this ingredient by itself or prove clinical synergy.
The cosmetic ingredient name commonly used for GHK-Cu; this is a naming cross-reference, not a second independently proven hair-growth compound.
Hydrolyzed collagen taken orally. Some specified products improved skin elasticity in human trials; results for hydration and other endpoints are mixed and product-specific.
A cosmetic ingredient often included in blends. Laboratory inflammation markers do not by themselves establish reduced skin aging in people.
A marketed cosmetic pentapeptide. The reviewed hub sources do not establish an independent clinical benefit or synergy with Argireline.
Cosmetic octapeptide with supplier laboratory and small volunteer findings. Separate supplier tests do not establish superiority to Argireline or equivalence to an injected drug.
Formulation matters: Human findings for one finished product do not establish the same result or tolerability for every serum, oral supplement or injectable preparation.
Peptide Dossier Editorial Team · Editorial source reconciliation October 27, 2026. Selected primary abstracts were checked; full trial papers were not obtained for this hub check. Supplier findings remain attributed. No clinician review was performed. Methods · Disclosures · Corrections · Explore skin research.